NeuroSense Therapeutics Net Tangible Assets

NeuroSense Therapeutics posts a net tangible assets of $-1.6M as of December 2025. That compares with $2.6M in the prior-year period — down 160.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, NeuroSense Therapeutics's net tangible assets was $2.6M. The latest reading is $-1.6M — a 160.4% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Net Tangible Assets is one piece of NeuroSense Therapeutics's financial statement story. At $-1.6M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NRSN's net tangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NeuroSense Therapeutics's other metric pages and overview cover the third.